![](/img/cover-not-exists.png)
Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose study
Tingley, W., Luca, D., Leabman, M., Budha, N., Kahn, R., Baruch, A., Cowan, K., Davis, J. C.Volume:
34
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/eht309.p4183
Date:
August, 2013
File:
PDF, 53 KB
english, 2013